ISOPP Contributes to Global Health Policy

ISOPP Contributes to Global Health Policy              

We are proud to share that several ISOPP members from the ISOPP Advocacy committee, chaired by Esin Kandemir, played a pivotal role in shaping the 25th WHO Expert Committee on the Selection and Use of Essential Medicines report.

Their expertise in oncology pharmacy helped guide decisions that impact access to essential cancer treatments worldwide. Theis work highlights the value of oncology pharmacy voices in global essential medicines policy.

Link to the WHO report 

Related News

ISOPP News

A joint statement from UICC and ISOPP on the alarming findings reported in The Lancet Global Health that reveal approximately one in six anticancer medication samples collected from public hospitals and private pharmacies across multiple countries in sub-Saharan Africa failed to meet international pharmaceutical standards.

ISOPP News

From Netty Cracknell, ISOPP President I hope this message finds you well and that you are enjoying the start of summer (or winter for those in the southern hemisphere!).

ISOPP News

From Netty Cracknell, ISOPP President As we approach the midpoint of the year, I find myself reflecting on the immense passion, compassion, and resilience that defines our global oncology pharmacy community. From quiet moments at the compounding bench to international collaboration and groundbreaking innovation, the work we do matters—deeply.